QS Batterymarch Financial Management’s Pacific Biosciences PACB Stock Holding History

QS Batterymarch Financial Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$14K	Buy	+2,707	New	+$14.2K	﹤0.01%	842

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Batterymarch Financial Management's PACB Position: Q3 2014 in Review

QS Batterymarch Financial Management opened a new position in Pacific Biosciences (PACB) in Q3 2014: 2,707 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #842 among its holdings.

88 funds tracked by Wall St. Rank hold PACB as of Q3 2014.

QS Batterymarch Financial Management held 2,707 shares of Pacific Biosciences worth $14K as of Q3 2014.
Pacific Biosciences was a new QS Batterymarch Financial Management position in Q3 2014.
Pacific Biosciences made up ﹤0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #842 holding.
88 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.